Skip to main content
. 2013 Jul 1;188(1):60–68. doi: 10.1164/rccm.201209-1697OC

TABLE 2.

ENDOTHELIAL MICROPARTICLE COUNTS BY COPD SEVERITY

  Control Subjects (n = 76) Mild (n = 39) Moderate (n = 45) Severe (n = 19) P Value for Linear Trend Across COPD Severity
CD31+ endothelial microparticles per microliter, log-transformed
 Mean (SD)
7.11 (0.58)
7.12 (0.49)
7.26 (0.71)
7.52 (0.51)
0.01
 Predicted mean, model 1*
7.10
7.30
7.27
7.49
0.02
 Predicted mean, model 2
7.10
7.32
7.30
7.51
0.01
 Predicted mean, model 3§
7.07
7.31
7.27
7.40
0.03
CD51+ endothelial microparticles per microliter, log-transformed
 Mean (SD)
6.80 (0.79)
6.91 (0.68)
6.94 (0.78)
7.17 (0.83)
0.07
 Predicted mean, model 1
6.80
7.06
6.89
7.00
0.43
 Predicted mean, model 2
6.80
7.08
6.94
7.02
0.80
 Predicted mean, model 3
6.71
7.12
6.85
6.83
0.47
CD62E+ endothelial microparticles per microliter, log-transformed
 Mean (SD)
5.98 (0.62)
6.09 (0.68)
6.02 (0.71)
6.35 (0.69)
0.047
 Predicted mean, model 1
5.98
6.15
6.11
6.53
0.05
 Predicted mean, model 2
5.98
6.16
6.12
6.54
0.05
 Predicted mean, model 3 5.98 6.22 6.11 6.51 0.03

Definition of abbreviations: COPD = chronic obstructive pulmonary disease.

*

Model 1 adjusted for age, sex, race and ethnicity, and cohort.

P value less than 0.05, compared with control subjects.

Model 2 adjusted for variables in model 1 in addition to smoking status, and pack-years.

§

Model 3 adjusted for variables in model 2 in addition to educational attainment, body mass index, height, weight, diabetes mellitus, hypertension, oxygen saturation, white blood cell count, sleep apnea, high-density lipoprotein, and statin use.